Rapid Infusion
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety Analysis of Intravenous Rapid Infusion of Obinutuzumab in Patients With B-cell Non-Hodgkin's Lymphoma in China (NCT05510219) | The First Affiliated Hospital with Nanjing Medical University | 2022-01-01 |
Track Rapid Infusion automatically
Every clearance here is in the API, with alerts when new ones post.